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INTRODUCTION
Lubag disease, X-linked dystonia-parkinsonism
(XDP), is an X-linked recessive progressive neurode-
generative dystonia-parkinsonism that is endemic to
the island of Panay in the Philippines (1, 2). The
onset of XDP occurs in adulthood and by the end
of the third or early fourth decade manifests pre-
dominantly as dystonia. Dystonia usually manifests
focally and becomes generalized or multifocal after
5 years in most patients. The disease plateaus until
the 10th year of the illness and then its severity
reduces or is replaced by Parkinsonian symptoms
by the 15th year of illness (1, 2). Evidente et al.
reported the first case of XDP that demonstrated a
good response to bilateral pallidal stimulation un-
der local anesthesia (3). Here, we report a case of
XDP who presented to us for deep brain stimula-
tion (DBS) under general anesthesia.
CASE PRESENTATION
The patient was a 49-year old Filipino male
(height, 162 cm ; weight, 45 kg) having maternal
roots in the Philippine Island of Panay. He first pre-
sented with involuntary movements of bilateral hallu-
ces at the age of 41 years. The condition began with
involuntary movements, his ambulatory ability wors-
ened progressively and he developed generalized
dystonia. On presentation, the patient had dystonic
symptoms mainly on the left side of his body with a
retracted head, twisted trunk, and involuntary move-
ments of his upper limbs. He also had difficulty
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walking and dysarthria because of a twisted trunk ;
however, no communication difficulties were ob-
served.
Magnetic resonance imaging (MRI) studies re-
vealed atrophy of the caudate and putamen. The
patient had a medical history of hypertension with-
out medication and a family history of dystonia.
His mother was unaffected carrier and his elder
brother had dystonia.
No premedication was administered. An electro-
cardiography was conducted in the patient. His oxy-
gen saturation, heart rate, body temperature, and
urine output volume were monitored. Anesthesia
was induced with propofol (1.3 mg/kg), remifen-
tanil (0.3 μg/kg/min), and rocuronium bromide
(0.6 mg/kg). A stereotactic frame was fixed to the
patient’s skull in the operating room after tracheal
intubation. The patient was transferred to the MRI
suite to identify target nuclei and determine surgi-
cal planning. Anesthesia was maintained during MRI
with intravenous fentanyl (100 μg), midazolam (10
mg), and rocuronium bromide (30 mg), and the pa-
tient was returned to the operating room 1 h after
MRI. A burr hole was made in the cranium to in-
sert a DBS electrode that was passed down to the
target area using microelectrode recording (MER)
to identify brain structures and conduct clinical test-
ing. Specific brain structures were identified based
on the unique MER neuronal firing patterns, and the
electrode was inserted at the exact target location.
Anesthesia was maintained with infusions of pro-
pofol (4.0 mg/kg/h), remifentanil (0.3 μg/kg/min),
sevoflurane (0.8%), and rocuronium bromide (3.7
μg/kg/min). A pulse generator was subsequently
implanted in the subclavicular subcutaneous area
and connected to the electrode extension cable. An-
esthesia was maintained during this procedure with
sevoflurane (1.0-1.5%), remifentanil (0.15-0.3 μg/
kg/min), and rocuronium bromide (3.7 μg/kg/
min). This patient did not present with Parkinsonian
symptoms at the time of surgery. After the surgery,
sugammadex (4 mg/kg) was injected and the pa-
tient regained consciousness. He was alert and ori-
ented and therefore extubated. Total surgical time
was 434 min, and anesthesia time was 591 min. To-
tal infusion volume was 2,900 ml, bleeding was 80
ml, and urine output volume was 2,025 ml.
The stimulation was started 1 day after the sur-
gery, and involuntary movements of the patent’s
upper limbs, difficulty walking, and dysarthria im-
proved markedly within 10 days.
DISCUSSION
DBS is used for treating patients with neurogenic
disorders such as Parkinson’s disease, essential
tremors, dystonia, and certain psychiatric conditions
(4). DBS is a procedure that includes placing elec-
trodes into deep brain structures. The DBS elec-
trode is connected to an implantable pulse genera-
tor (5).
Anesthetic techniques vary depending on the tra-
ditions and requirements of each institution per-
forming these procedures (5, 6). In our hospital, a
stereotactic frame is usually placed on the patient’s
skull followed by MRI for targeting using three-
dimensional optical marker-based technology under
local anesthesia. After MRI, general anesthesia is
initiated to insert the electrode into the target area
for stimulation and implantation of the pulse gen-
erator in the subclavicular subcutaneous area.
The awake technique has an obvious advantage
during the mapping phase because it accurately de-
tects cellular activity and movement-related re-
sponses to neurostimulation (5). In addition, if the
patient is conscious and cooperative, intraoperative
electrical stimulation and clinical improvement can
be observed (7).
However, general anesthesia may be necessary
in children and adults who cannot tolerate the awake
technique. Total intravenous and inhalation anes-
thesia have been used in patients who are consid-
ered unsuitable for the awake technique (5, 8, 9).
In this case, the patient presented with severe dysto-
nia and was restless ; therefore, general anesthesia
was selected.
Intravenous anesthesia is preferred over volatile
anesthesia for DBS anesthetic management in many
cases (8, 9). It is unclear which general anesthesia
agents are the most effective and suitable for this
procedure. Trombetta et al. reported delayed awak-
ening after propofol anesthesia during DBS for
dystonia (10) ; therefore, we used low dose sevoflu-
rane to minimize propofol dose. Propofol administra-
tion was stopped when the pulse generators were
implanted in the subclavicular subcutaneous area.
Propofol causes a significant decrease in target
nuclei neuronal activity (7, 8). Steigerwald et al. re-
ported that overall neuronal firing rates in patients
with dystonia decrease (11), differences in globus
pallidus internus neuronal firing rates occur between
patients with dystonia and Parkinson’s disease, and
the effect of anesthesia may be more pronounced
in patients with Parkinson’s disease (5). These
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changes may interfere with localization of MER-
based DBS electrodes (6) ; therefore, administering
propofol before electrophysiological mapping begins
is not recommended (10). In addition, Pralong et al.
reported that low doses of propofol and sevoflu-
rane influence pallidal activity in a similar way (12) ;
therefore, studies to prove the anesthetic agents
that are the most effective and suitable for this sur-
gery must be conducted.
We anesthetized a patient with XDP disease who
underwent DBS. XDP is a rare disease and its
mechanism is unclear ; however, the operation was
completed safely by the same anesthesia method
as the one for other dystonia patients.
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